Advertisement

novartis

Swiss pharma stocks fall after Trump speech
Trump

Swiss pharma stocks fall after Trump speech

Swiss pharmaceutical firms saw their stock prices drop on Thursday morning after US President-elect Donald Trump used part of his chaotic press conference the day before to say the US should negotiate better prices from drug companies.
Swiss pharma giant buys US sickle cell lab
doctors

Swiss pharma giant buys US sickle cell lab

Swiss-based pharmaceuticals giant Novartis said on Monday it was acquiring Selexys Pharmaceuticals Corp., a US research lab in blood and inflammatory disorders, in a deal costing up to $665 million (627 million euros).